Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Proteoglycans: potential agents in mammographic density and the associated breast cancer risk|
|Citation:||Journal of Mammary Gland Biology and Neoplasia, 2015; 20(3-4):121-131|
|Michael S. Shawky, Carmela Ricciardelli, Megan Lord, John Whitelock, Vito Ferro, Kara Britt, Erik W. Thompson|
|Abstract:||Although increased mammographic density (MD) has been well established as a marker for increased breast cancer (BC) risk, its pathobiology is far from understood. Altered proteoglycan (PG) composition may underpin the physical properties of MD, and may contribute to the associated increase in BC risk. Numerous studies have investigated PGs, which are a major stromal matrix component, in relation to MD and BC and reported results that are sometimes discordant. Our review summarises these results and highlights discrepancies between PG associations with BC and MD, thus serving as a guide for identifying PGs that warrant further research towards developing chemo-preventive or therapeutic agents targeting pre-invasive or invasive breast lesions, respectively.|
|Keywords:||Breast cancer; Extracellular matrix; Glypican; Heparanase; Mammographic density; Perlecan; Proteoglycans; Syndecan; Versican|
|Rights:||© Springer Science+Business Media New York 2015|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.